Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture
Authors' conclusion
Professionals and persons with osteoporosis were supportive of the proposed DA and its usability.
Study context
- Population
- Patients visiting the fracture liaison service with a recent fracture and osteoporosis or a prevalent vertebral fracture
- Participants
- 15 alpha testing patients
- Outcome
- Alpha testing of the DA
Methodological detailsdeveloped according to International Patient Decision Aid Standards (IPDAS), scope, design, prototype development and alpha testing, A previously developed decision aid (DA) for women with osteoporosis was used as a basis, with input from literature searches, the Dutch osteoporosis guideline and people with a fracture or osteoporosis
- Developed according to IPDAS
- Scope, design, prototype development and alpha testing
- A previously developed DA for women with osteoporosis was used as a basis, with input from literature searches, the Dutch osteoporosis guideline and people with a fracture or osteoporosis
Main finding
As reported in the abstract
- Patient preferences and needs adequately presented
- Several suggestions for improvement (e.g. more specific information, simpler terminology, better icon use) accounted for
- Participants recommended use of the DA during outpatient visits
Original publication
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture. Osteoporos Int. Published 21 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →